TrioxBio ^{For Profit}

TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO). With this, TrioxBio can provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas.